However, IHC analysis indicated that the expression of the cell proliferation marker PCNA dramatically decreased in the tumor samples retrieved from the monensin treatment group, compared with that of the control group (Fig. 7C, panel b). The gene discussed is PCNA; the disease is neoplasm.